Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin
Authors:
- Hideo KohnoHKHideo Kohno
- Tsutomu SakaiTSTsutomu Sakai
- Saburo SaitoSSSaburo Saito
- Kiichiro OkanoKOKiichiro Okano
- Kenji KitaharaKKKenji Kitahara
- 1 March 2007
- journal article
- Published by Elsevier in Experimental Eye Research
- Vol. 84 (3) , 569-576
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphateExperimental Eye Research, 2006
- Multiplex Cytokine Detection versus ELISA for Aqueous Humor: IL-5, IL-10, and IFNγ Profiles in UveitisInvestigative Ophthalmology & Visual Science, 2006
- Effect of Atorvastatin (80 mg/day) Versus Pravastatin (40 mg/day) on Arterial Remodeling at Coronary Branch Points (from the REVERSAL Study)The American Journal of Cardiology, 2005
- The effects of atorvastatin in experimental autoimmune uveitisBritish Journal of Ophthalmology, 2005
- Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitisGene Therapy, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Suppression of Experimental Autoimmune Uveoretinitis by Anti-αβ TCR Monoclonal AntibodyJapanese Journal of Ophthalmology, 2002
- Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages.Journal of Clinical Investigation, 1997
- Role of mevalonic acid in the regulation of natural killer cell cytotoxicityJournal of Cellular Physiology, 1989
- S-antigen: identification of the MAbA9-C6 monoclonal antibody binding site and the uveitopathogenic sitesCurrent Eye Research, 1986